# Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

> **NCT00755833** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 270 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart 50

## Key facts

- **NCT ID:** NCT00755833
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2016-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755833, "Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00755833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*